Puma Biotechnology Inc (PBYI) Free Cash Flow by Year
Puma Biotechnology Inc generated $41.7M in free cash flow in fiscal year 2025. This represents an increase of 7.4% from the prior fiscal year. Over the trailing 12 months, Q3 FY2025 through Q2 FY2026, the same line adds up to $41.1M in free cash flow. The table below carries 15 fiscal years, from 2011 to 2025, and the quarters Puma Biotechnology Inc has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
PBYI Free Cash Flow by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
| Metric | TTM | FY2510-K | FY2410-K | FY2310-K | FY2210-K | FY2110-K | FY2010-K | FY1910-K | FY1810-K | FY1710-K | FY1610-K | FY1510-K | FY1410-K | FY1310-K | FY1210-K | FY1110-K |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | $41.1M | $41.7M+7.4% | $38.9M+44.6% | $26.9M+269.8% | -$15.8M-176.6% | $20.6M+2740.4% | $727K-96.7% | $22.1M+189.9% | -$24.5M+85.8% | -$172.9M-18.4% | -$146.0M+6.1% | -$155.5M-98.5% | -$78.3M-40.7% | -$55.7M | N/A | -$2.1M |
TTM is the trailing twelve months, Q3 FY2025 through Q2 FY2026, summed from the four most recent quarterly filings.
PBYI Free Cash Flow by Quarter
Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.
What free cash flow means
Free cash flow is the cash operations produced over the period, less what the company spent on property, plant and equipment, so it answers what was left over rather than what was earned on paper.
More Puma Biotechnology Inc financials
Frequently Asked Questions
What was Puma Biotechnology Inc's free cash flow in fiscal year 2025?
Puma Biotechnology Inc generated $41.7M in free cash flow in fiscal year 2025.
How fast is Puma Biotechnology Inc's free cash flow growing?
Puma Biotechnology Inc (PBYI) free cash flow rose by 7.4% year over year, from $38.9M to $41.7M in fiscal year 2025.
What is Puma Biotechnology Inc's free cash flow over the last twelve months?
Puma Biotechnology Inc (PBYI) reported $41.1M in free cash flow over the trailing 12 months, Q3 FY2025 through Q2 FY2026, summed from the four most recent quarterly filings.
How has Puma Biotechnology Inc's free cash flow changed over the years?
Across the 15 fiscal years this page covers, Puma Biotechnology Inc (PBYI) free cash flow went from -$2.1M in fiscal year 2011 to $41.7M in fiscal year 2025.
What was Puma Biotechnology Inc's free cash flow in the most recent quarter?
Puma Biotechnology Inc (PBYI) reported $1.6M in free cash flow in Q2 2026. This represents a decrease of 88.5% from the same quarter a year earlier.
What does free cash flow mean on a financial statement?
Free cash flow is the cash operations produced over the period, less what the company spent on property, plant and equipment, so it answers what was left over rather than what was earned on paper. This page lists what Puma Biotechnology Inc (PBYI) reported on that line in every period on record.